Tear production after unilateral removal of the main lacrimal gland in squirrel monkeys

Archives of Ophthalmology

Volumn 118, Issue 2, 2000, Pages 246-252

  Maitchouk, Dmitri Y ^a   Beuerman, Roger W ^a,c   Ohta, Toshihiko ^a   Stern, Michael ^b   Varnell, Ray J ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b ALLERGAN INC   (United States)

^c LSU EYE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; DISEASE ASSOCIATION; EYE SURGERY; FEMALE; KERATOCONJUNCTIVITIS; LACRIMAL GLAND; LACRIMATION; MALE; NONHUMAN; PRIORITY JOURNAL; SCHIRMER TEST; SQUIRREL MONKEY;

EID: 0033961056     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.118.2.246     Document Type: Article

References (47)

1. Farris RL. Abnormalities of the tears and treatment of dry eyes. In: Kaufman HE, Barron BA, McDonald MB, eds. The Cornea. 2nd ed. Boston, Mass: Butterworth-Heinemann; 1998:109-129.
2. Lemp MA, Wolfley DE. The lacrimal apparatus. In: Hart WM Jr, ed. Adler's Physiology of the Eye. 9th ed. St Louis, Mo: Mosby-Year Book Inc; 1992:18-28.
3. Jones LT. The lacrimal tear system and its treatment. Am J Ophthalmol. 1966; 62:47-60.
4. Jordan A, Baum J. Basic tear flow: does it exist? Ophthalmology. 1980;87:920-930.
5. Lemp MA. Recent developments in dry eye management. Ophthalmology. 1987; 94:1299-1304.
6. Stein R, Hurwitz JJ. Anatomy and physiology of tear secretion. In: Hurwitz JJ, ed. The Lacrimal System. New York, NY: Lippincott-Raven; 1995:1-8.
7. Beuerman RW, McDonald MB, Zhang D, Varnell RJ, Thompson HW. Diclofenac sodium attenuates neural activity after photorefractive keratectomy in rabbits. J Refract Surg. 1996;12:783-791.
8. Beuerman RW, Maitchouk DY, Varnell RJ, Pedroza-Schmidt L. Interactions between lacrimal function and the ocular surface. In: Kinoshita S, Ohashi Y, eds. Proceedings ot the 2nd Annual Meeting of the Kyoto Cornea Club. The Hague, the Netherlands: Kugler Publications; 1998:1-10.
9. Mathers WD, Lane JA, Sutphin JE, Zimmerman MB. Model for ocular tear film function. Cornea. 1996;15:110-119.
10. Arffa RC. Diseases of the Cornea. St Louis, Mo: Mosby-Year Book Inc; 1991.
11. van Haeringen NJ. Clinical biochemistry of tears. Surv Ophthalmol. 1981;26:84-96.
12. Sullivan DA, Sato EH. Potential therapeutic approach for the hormonal treatment of lacrimal gland dysfunction in Sjogren's syndrome. Clin Immunol Immunopathol. 1992;64:9-16.
13. Holly FJ, Lemp MA. Tear physiology and dry eyes. Surv Ophthalmol. 1977;22: 69-87.
14. van Bijsterveld OP. Diagnosis and differential diagnosis of keratoconjunctivitis sicca associated with tear gland degeneration. Clin Exp Rheumatol. 1990;8 (suppl 5):3-6.
15. Mathers WD, Lane JA, Zimmerman MB. Tear film changes associated with normal aging. Cornea. 1996;15:229-234.
16. Danjo Y, Lee M, Horimoto K, Hamano T. Ocular surface damage and tear lactoferrin in dry eye syndrome. Acta Ophthalmol (Copenh). 1994;72:433-437.
17. Vangveeravong S, Katz SE, Rootman J, White V. Tumors arising in the palpebral lobe of the lacrimal gland. Ophthalmology. 1996;103:1606-1612.
18. Mombaerts I, Schlingemann RO, Goldschmeding R, Noorduyn LA, Koornneef L. The surgical management of lacrimal gland pseudotumors. Ophthalmology. 1996; 103:1619-1627.
19. Massry GG, Harrison W, Hornblass A. Clinical and computed tomographic characteristics of amyloid tumor of the lacrimal gland. Ophthalmology. 1996;103: 1233-1236.
20. Takeshita S, Sugai S, Ogawa Y, et al. A case of Sjogren's syndrome with an eye-lid tumor, a so-termed pseudolymphoma of the lacrimal gland. Ryumachi. 1996; 36:43-49.
21. Jakobiec FA, Font RL. Orbit: noninfectious orbital inflammation. In: Spencer WH, ed. Ophthalmic Pathology: An Atlas and Textbook. Vol 3. 3rd ed. Philadelphia, Pa: WB Saunders Co; 1985:2777-2795.
22. Scherz W, Dohlman CH. Is the lacrimal gland dispensable? keratoconjunctivitis sicca alter lacrimal gland removal. Arch Ophthalmol. 1975;93:281-283.
23. Parsons JT, Bova FJ, Mendenhall WM, Million RR, Fitzgerald CR. Response of the normal eye to high dose radiotherapy. Oncology. 1996;10:837-847.
24. Whitcher JP. Clinical diagnosis of the dry eye. Int Ophthalmol Clin. 1987;27: 7-24.
25. Mackie IA, Seal DV. The questionably dry eye. Br J Ophthalmol. 1981;65:2-9.
26. van Bijsterveld OP. Diagnostic tests in the sicca syndrome. Arch Ophthalmol. 1969;82:10-14.
27. Varnell RJ, Freeman JY, Maitchouk D, Beuerman RW, Gebhardt BM. Detection of substance P in human tears by laser desorption mass spectrometry and immunoassay. Curr Eye Res. 1997;16:960-963.
28. Maitchouk DY, Varnell RJ, Beuerman RW, Yan J. Analyzing proteins in tears from patients with dry eye syndrome, with contact lenses, or undergoing photorefractive keratectomy [abstract]. Invest Ophthalmol Vis Sci. 1996;37(suppl). S18.
29. Beuerman RW, Pedroza L. Ultrastructure of the human cornea. Microsc Res Tech. 1996;33:320-335.
30. Helper LC, Magrane WG, Koehm J, Johnson R. Surgical induction of keratoconjunctivitis sicca in the dog. J Am Vet Med Assoc. 1974;165:172-174.
31. McLaughlin SA, Brightman AH 2nd, Helper LC, Primm ND, Brown MG, Greeley S. Effect of removal of lacrimal and third eyelid glands on Schirmer tear test results in cats. J Am Vet Med Assoc. 1988;193:820-822.
32. Jester JV, Nicholaides N, Kiss-Palvolgyi I, Smith RE. Meibomian gland dysfunction, II: the role of keratinization in a rabbit model of MGD. Invest Ophthalmol Vis Sci. 1989;30:936-945.
33. Maudgal PC. The epithelial response in keratitis sicca and keratitis herpetica (an experimental and clinical study). Doc Ophthalmol. 1978;45:223-327.
34. Stephens LC, Schultheiss THE, Ang KK, Gray KN, Peters LJ. Anatomy of the major lacrimal gland of rhesus monkeys (Macaca mulatta). J Med Primatol. 1987; 16:407-419.
35. Gilbard JP, Rossi SR, Gray KL. A new rabbit model for keratoconjunctivitis sicca. Invest Ophthalmol Vis Sci. 1987;28:225-228.
36. Mackor AJ, van Bijsterveld OP. Tear function parameters in keratoconjunctivitis sicca with and without the association of Sjogren's syndrome. Ophthalmologica. 1988;196:169-174.
37. Yoshino K, Monroy D, Pflugfelder SC. Cholinergic stimulation of lactoferrin and epidermal growth factor secretion by the human lacrimal gland. Cornea. 1996; 15:617-621.
38. Nakamori K, Odawara M, Nakajima T, Mizutani T, Tsubota K. Blinking is controlled primarily by ocular surface conditions. Am J Ophthalmol. 1997;124: 24-30.
39. McGill JI, Liakos GM, Goulding N, Seal DV. Normal tear protein profiles and age-related changes. Br J Ophthalmol. 1984;68:316-320.
40. Newell FW. Ophthalmology. St Louis, Mo: CV Mosby Co; 1986:42-80.
41. Vanley GT, Leopold IH, Gregg TH. Interpretation of tear film breakup. Arch Ophthalmol. 1977;95:445-448.
42. Seifert P, Spitznas M. Demonstration of nerve fibers in human accessory lacrimal glands. Graefes Arch Clin Exp Ophthalmol. 1994;232:107-114.
43. Seifert P, Spitznas M, Koch F, Cusumano A. Light and electron microscopic morphology of accessory lacrimal glands. Adv Exp Med Biol. 1994;350:19-23.
44. Yoshino K, Tseng SC, Pflugfelder SC. Substrate modulation of morphology, growth, and tear protein production by cultured human lacrimal gland epithelial cells. Exp Cell Res. 1995;220:138-151.
45. Karas M, Bahr U, Giebmann U. Matrix-assisted laser desorption ionization mass spectrometry. Mass Spectrom Rev. 1992;10:335-357.
46. Van Setten GB, Schultz GS, Macauley S. Growth factors in human tear fluid and in lacrimal glands. Adv Exp Med Biol. 1994;350:315-319.
47. Van Setten G, Schultz G. Transforming growth factor-alpha is a constant component of human tear fluid. Graefes Arch Clin Exp Ophthalmol. 1994;232:523-526.